PSP Research »

Ascendis Pharma AS shares owned by PSP Research

Quarter-by-quarter ownership of Ascendis Pharma AS shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by PSP Research

Quarter filed Position value Share count Share price at filing
2026-06-30 $400k 1.5k 266.72

More positions owned by PSP Research

Spdr Series Trust St Str Sp Biot (XBI)
Ishares Tr 0-3 Mth Treasury (SGOV)
Royalty Pharma Shs Class A (RPRX)
Nurix Therapeutics (NRIX)
Incyte Corporation (INCY)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Rapport Therapeutics (RAPP)
Ultragenyx Pharmaceutical (RARE)
Trevi Therapeutics (TRVI)
Monte Rosa Therapeutics (GLUE)
Tg Therapeutics (TGTX)
Halozyme Therapeutics (HALO)
Ionis Pharmaceuticals (IONS)
Pharvaris N V (PHVS)

View all positions for PSP Research

Top funds holding Ascendis Pharma AS

A.R. Schmeidler & Co
Driehaus Capital Management
Q Global Advisors
Sapient Capital
Tudor Investment Corporation
Handelsbanken Fonder AB
Henry James International Management
Evolutionary Tree Capital Management
Ohio Pers
Legato Capital Management
PSP Research
Assenagon Asset Management
GAMMA Investing
Massmutual Trust
SBI Securities

View all funds holding Ascendis Pharma AS